by J. Morgan Micheletti, MD
Uncover the fascinating evolution of modern eyecare with "The History of Eyecare." Hosted by J. Morgan Micheletti, MD, a dedicated eye surgeon and history enthusiast, this podcast takes you on a journey through eyecare's landmark moments and untold stories as told by thought leaders, innovators, and legends who have shaped the field. From anterior segment and refractive surgery to retina, plastics, and glaucoma, every facet of eyecare's rich history is explored, helping us better understand and shape the future. Subscribe and join us as we reveal the milestones that have revolutionized eyecare.
Language
🇺🇲
Publishing Since
6/23/2023
Email Addresses
1 available
Phone Numbers
0 available
February 14, 2025
Dr. Stephen Lane shares his journey into medicine and ophthalmology, his experiences in research, innovation, and teaching, as well as his involvement with Orbis. He discusses his father's influence, his decision to pursue ophthalmology, and his work with Alcon. Dr. Lane also highlights his research on corneal transplants, intraocular lenses, and bimanual INA, as well as his teaching experiences and involvement with Orbis. Dr. Stephen Lane discusses his experiences with Orbis, the establishment of a cataract program, and his transition to becoming CMO at Alcon. He also shares insights on industry innovation and the future of ophthalmology. Takeaways Dr. Lane's journey into ophthalmology was influenced by his father's experience and advice, leading him to pursue a career in medicine and ophthalmology. His research and innovation in corneal transplants, intraocular lenses, and bimanual INA have contributed significantly to the field of ophthalmology. Dr. Lane's dedication to teaching and his involvement with Orbis reflect his commitment to sharing knowledge and improving access to eye care globally. Dr. Lane's involvement with Orbis and the establishment of a cataract program highlights the importance of providing surgical care in disadvantaged communities. The transition to becoming CMO at Alcon allowed Dr. Lane to contribute to industry innovation and strategic decision-making. Efficiency and innovation in ophthalmology, particularly in diagnostic instruments and surgical procedures, are crucial for meeting the growing patient needs and expectations. The impact of life cycle innovation in Faco and the potential of AI and cell therapy in ophthalmology are significant areas of development and change in the field. Keywords medicine, ophthalmology, research, innovation, teaching, Alcon, corneal transplants, intraocular lenses, bimanual INA, Orbis, Orbis, cataract program, Alcon, chief medical officer, industry innovation, ophthalmology, future of ophthalmology
December 6, 2024
Renowned ophthalmologist Samuel Masket, MD, shares his journey into medicine, pioneering cataract surgery advancements, and establishing the Masket Foundation to support underserved patients.
October 11, 2024
Dr. Marguerite McDonald shares her journey in medicine and ophthalmology, from her childhood experiences with poor vision to her groundbreaking work in refractive surgery. She recounts her introduction to ophthalmology through a retinoblastoma clinic and her research on isoenzyme patterns in retinoblastoma. Dr. McDonald discusses her residency and fellowship experiences, including her involvement in the PERK study on radial keratotomy. She then delves into the development of the excimer laser and the challenges and controversies she faced during the early stages of laser vision correction. Finally, she reflects on the current state of LASIK and the advancements in refractive surgery. In this conversation, Dr. Marguerite McDonald discusses her experiences and contributions in the field of ophthalmology. She talks about the challenges with LASIK and the importance of highlighting successful outcomes. Dr. McDonald also shares her journey as the first female president of ASCRS and ISRS, and her involvement with Ophthalmic Women Leaders (OWL). She reflects on her most meaningful contributions to the field, including her work on retinoblastoma and laser vision correction. Finally, Dr. McDonald discusses exciting developments in the field, such as the EVO ICL and temporary procedures for presbyopia. Takeaways Dr. Marguerite McDonald's journey in medicine and ophthalmology was shaped by her personal experiences with poor vision and her desire to help others see. Her research on isoenzyme patterns in retinoblastoma and her work on the PERK study on radial keratotomy were significant contributions to the field of ophthalmology. Dr. McDonald played a pivotal role in the development of laser vision correction, including the use of the excimer laser and the transition to LASIK. Despite facing controversy and skepticism, Dr. McDonald's dedication to data-driven research and patient care has helped shape the field of refractive surgery. Highlighting successful outcomes is important to counteract negative publicity and encourage more suitable candidates to proceed with LASIK. Dr. Marguerite McDonald's journey as the first female president of ASCRS and ISRS highlights the progress made in promoting diversity and gender equality in the field of ophthalmology. Ophthalmic Women Leaders (OWL) provides a platform for networking and professional development for women in the ophthalmology industry. Dr. McDonald's contributions to the field include her work on retinoblastoma, laser vision correction, and the development of the EVO ICL. Chapters with Timestamps 00:00 - Introduction and Early Life 00:40 - The Near-Drowning Incident and Discovery of Myopia 03:00 - First Glasses and Introduction to Optometry 05:23 - Medical School Challenges and Rotation in Retinoblastoma 07:45 - Research on Retinoblastoma Isoenzymes 10:06 - Internship at Lenox Hill and Residency at Manhattan Eye 12:23 - Residency Interview Experiences and Film Festival Award 14:45 - LSU Fellowship and Refractive Surgery Involvement 17:08 - Work on Epicardifakia and Radial Keratotomy Research 19:34 - Transition to Excimer Laser Development 21:59 - Early Laser Research Challenges 24:29 - Animal Testing, First Human Case, and FDA Interactions 26:52 - The Alberta Cassidy Case and Human Trials 29:18 - LSU Trailer Experiments and Data Findings 31:40 - Controversy Over Blind Eye Study 34:01 - Advances in Laser Technology and Flying Spot Lasers 36:26 - First Sighted Patients and Scrutiny 38:48 - Evolution of LASIK and Femtosecond Lasers 41:11 - Barriers to LASIK Adoption 43:36 - Leadership Roles and Breaking Barriers 46:02 - Founding of OWL and Professional Networking 48:21 - Reflections on Career Achievements 50:49 - Exciting Future Developments in Ophthalmology 51:52 - Closing Remarks and Sponsor Acknowledgments
Cataract Coach with Uday Devgan MD
Cataract and Refractive Surgery Today
Eyetube
Zale Mednick
American Academy of Ophthalmology
MayoClinicOphthalmology
Retina Today
Human Content
Dr. Jim Dahle of the White Coat Investor
The New York Times
All-In Podcast, LLC
Jason Bateman, Sean Hayes, Will Arnett
Tenderfoot TV
Desiring God
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.